Biogen (BIIB) Target Raised to $215 at Jefferies after Tecfidera Approved with Favorable Label
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
What Next for Biogen (BIIB)? Anlaysts Weigh In
March 27, 2013 5:43 PM EDTOn Tuesday Biogen's (NASDAQ: BIIB) Tecfidera/BG12 was approved by the FDA. In addition to approval, the drug's label is considered "clean" .
Commenting on news, analyst Brian Abrahams of Wells Fargo said, "Overall the label reads relatively favorably, in our view, as expected . . . all eyes will now... More
Biogen Idec (BIIB) Affirms Receipt of FDA Approval for TECFIDERA as MS Treatment
March 27, 2013 4:25 PM EDTToday Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS). Biogen Idec will make this oral capsule available to people living with MS in the United States in the coming days.
TECFIDERA has... More
UPDATE: Biogen Idec (BIIB) wins FDA approval for MS pill
March 27, 2013 3:34 PM EDT(Updated - March 27, 2013 3:35 PM EDT)
Biogen Idec, Inc. (NASDAQ: BIIB) wins FDA approval for MS pill.
UPDATE - The FDA release is below:
The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).
MS is a chronic, inflammatory, autoimmune disease of the central nervous system that disrupts communication between the brain and other parts of the body. It is among the most common causes of... More
